Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP668878.RAbDHRHURZSAIeqtkZOppyvgRc3LEqJX8vWsTjNDOhK_s130_assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668878.RAbDHRHURZSAIeqtkZOppyvgRc3LEqJX8vWsTjNDOhK_s130_provenance.
• NP435326.RA1WLK3OLGS82J1ZuOxrYfetuzyjsQ8Kh38ItJGwDMPUM130_assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435326.RA1WLK3OLGS82J1ZuOxrYfetuzyjsQ8Kh38ItJGwDMPUM130_provenance.
• NP487386.RA8RW0bU-v3Lk_LNDg0_OIqwN6LcsCrFwsdYmQZvgoN4Y130_assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487386.RA8RW0bU-v3Lk_LNDg0_OIqwN6LcsCrFwsdYmQZvgoN4Y130_provenance.
• NP550268.RADH26s1rDxQZZR8WwL_65TYPh4jMfVmZVGKXTa0HiEro130_assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550268.RADH26s1rDxQZZR8WwL_65TYPh4jMfVmZVGKXTa0HiEro130_provenance.
• NP550272.RAAoHazr5OiQD5A5PA7_xoxeqsyj9QI-9bp64uJZ0lJhc130_assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550272.RAAoHazr5OiQD5A5PA7_xoxeqsyj9QI-9bp64uJZ0lJhc130_provenance.
• NP900380.RAOefdooRobX-sRRafGSGCosO5NJTHwu7l627l46GBW3o130_assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900380.RAOefdooRobX-sRRafGSGCosO5NJTHwu7l627l46GBW3o130_provenance.
• assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP550275.RARST6_fwo_Se2skXJA-FqCSagKRC8P1vu4BREEF2f7e0130_assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550275.RARST6_fwo_Se2skXJA-FqCSagKRC8P1vu4BREEF2f7e0130_provenance.
• NP301150.RAqPHtupe4lsFboe5IWjBD4XU_QfdRP2nGo_gXFfpteiY130_assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301150.RAqPHtupe4lsFboe5IWjBD4XU_QfdRP2nGo_gXFfpteiY130_provenance.
• NP550270.RAKaAOKhLcpKiWJd9CsTGd2wdlb9d31c5N32DREeyc0w0130_assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550270.RAKaAOKhLcpKiWJd9CsTGd2wdlb9d31c5N32DREeyc0w0130_provenance.
• NP447469.RAvkpylxjj1_CXJXIY-gaZcuCUKHos02F9LwzymuOgROU130_assertion description "[Carcinogen-treated HGF x CDK4(R24C) mice bearing multiple autochthonous melanomas did not reject transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands, suggesting the development of tumor immunotolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447469.RAvkpylxjj1_CXJXIY-gaZcuCUKHos02F9LwzymuOgROU130_provenance.